ZANIDIP

This brand name is authorized in Austria, Australia, Brazil, Spain, Finland, France, Hong Kong, Ireland, Mexico, Tunisia, United Kingdom, South Africa

Active ingredients

The drug ZANIDIP contains one active pharmaceutical ingredient (API):

1 Lercanidipine UNII OA8TFX68PE - LERCANIDIPINE HYDROCHLORIDE

Lercanidipine is a calcium antagonist of the dihydropyridine group and inhibits the transmembrane influx of calcium into cardiac and smooth muscle. The mechanism of its antihypertensive action is due to a direct relaxant effect on vascular smooth muscle thus lowering total peripheral resistance. Read about Lercanidipine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZANIDIP Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08CA13	Lercanidipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8534E, 8679T
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525012040100703, 525014040104303, 525014040104403
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61653, 65379
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 013353, 013399, 563569, 585786
Country: FR	Base de données publique des médicaments	Identifier(s): 66394873, 69025707
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 101988, 13674, 147655, 147657, 164493
Country: HK	Department of Health Drug Office	Identifier(s): 47384, 61340
Country: IE	Health Products Regulatory Authority	Identifier(s): 55849, 63804, 63815
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 135M2002
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7313082, 9024208
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/7.1/0113, A40/7.1/0106